Syncope resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 75: Line 75:
:❑ Implantable cardioverter defibrillator: VT with [[heart disease]], EPS induced [[VT]] in patients with previous [[MI]], [[VT]] and [[inherited cardiomyopathy]] </div>}}
:❑ Implantable cardioverter defibrillator: VT with [[heart disease]], EPS induced [[VT]] in patients with previous [[MI]], [[VT]] and [[inherited cardiomyopathy]] </div>}}
{{familytree/end}}
{{familytree/end}}
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. <ref name="pmid19713422‎">{{cite journal| author=Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A et al.| title=Guidelines for the diagnosis and management of syncope (version 2009). | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 21 | pages= 2631-71 | pmid=19713422‎ | doi=10.1093/eurheartj/ehp298 | pmc=PMC3295536 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19713422  }} </ref>
===Treatment of Syncope===
{{familytree/start}}
{{familytree | | | | A01 | | | | | | A02 | | | | A03 | | | | A01=Reflex and orthostatic intolerance | A02= Cardiac | A03= Unexplained and high risk [[SCD]] }}
{{familytree | | |,|-|^|-|.| | | |,|-|^|-|.| | | |!| | | | | | | | | }}
{{familytree | | B01 | | B02 | | B03 | | B04 | | B05 | B01=Unpredictable or high- frequency | B02= Predictable or low frequency | B03= Cardiac arrythmias [[SCD]]| B04=Structural (cardiac or pulmonary) | B05= i.e. [[CAD]], [[HOCM]], [[ARV]], channelopathies}}
{{familytree | | |!| | | |!| | | |!| | | |!| | | |!| }}
{{familytree | | C01 | | C02 | | C03 | | C04 | | C05 | C01=Consider specific therapy or delayed treatment based by [[ECG]] documentation | C02= Education, reassurance, avoidance of triggers | C03= Specfic therapy of the culprit arrythmia| C04=Treatment of underlying disease | C05= Consider [[ICD]] therapy}}
{{familytree/end}}


Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. <ref name="pmid19713422‎">{{cite journal| author=Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A et al.| title=Guidelines for the diagnosis and management of syncope (version 2009). | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 21 | pages= 2631-71 | pmid=19713422‎ | doi=10.1093/eurheartj/ehp298 | pmc=PMC3295536 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19713422  }} </ref>
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. <ref name="pmid19713422‎">{{cite journal| author=Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A et al.| title=Guidelines for the diagnosis and management of syncope (version 2009). | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 21 | pages= 2631-71 | pmid=19713422‎ | doi=10.1093/eurheartj/ehp298 | pmc=PMC3295536 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19713422  }} </ref>

Revision as of 20:53, 28 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]

Definition

Syncope is defined as a transient loss of consciousness due to cerebral hypoperfusion, characterized by a rapid onset, a short duration and a spontaneous complete recovery.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

Syncope in the Context of Transient LOC

 
 
 
 
 
 
Determine if there was LOC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes:

❑ It had a rapid onset?
❑ It was of short duration?
❑ Did the patient had a spontaneous
complete recovery?
 
 
 
 
No:
Cataplexy
❑ Drop attacks, falls
❑ Functional /psychogenic pseudosyncope
TIA of carotid origin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No to ≥ 1:
(exclude the following before
proceeding with syncope evaluation)
Coma
❑ Aborted SCD
Epilepsy
❑ Perform neurological evaluation
❑ Perform tilt testing, preferably with concurrent EEG
and video monitoring if doubt of mimicking epilepsy

❑ Metabolic disorders:

Hypoglycemia
Hypoxia
Hyperventilation with hypocapnia
Intoxication
❑ Vertebrobasilar TIA
 
Yes:

❑ Transient LOC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non traumatic
 
Traumatic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Syncope
 
Seizure
 
Psychogenic
 
 
 

Diagnostic and Treatment Flowchart in Patients with Suspected Syncope

 
 
 
 
 
Characterize symptoms
❑ ask for activity before incident
❑ ask for position before incident (supine, sitting, standing)
❑ ask for precipitating factors (stress, exercise, warm environment)
❑ look for prodrome (diaphoresis, nausea, blurry vision)
❑ inquire about duration (< 5 sec , > 5 sec)
❑ ask for medication intake (vasodilators, diuretics)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:
❑supine and standing BP measurement
hearth rate and breathing
cardiac auscultation
❑ examine for neurological symptoms
Order EKG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Absence of heart disease
❑ History of recurrent syncope
❑ After unpleasant sight or smell
❑ Associated to nausea
❑ Head rotation or pressure to carotid sinsus
 
❑ After standing up or prolonged standing
❑ Start of new vasodepresive drug
❑ Presence of autonomic neuropathy
❑ Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading.
 
❑ Presence of structural hearth disease
❑ During exertion
❑ Palpitations prior to LOC
Abnormal EKG findings:
❑ Bifascicular block, Wide QRS(≥ 0.12 s)
Mobitz I second degree AV block
❑ Non-sustained VT , Early repolarization
❑ Pre-excited QRS complexes
❑ Long or short QT intervals
❑ Q waves (myocardial infarction)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reflex
 
Orthostatic hypotension
 
Cardiovascular
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment
❑ Explain diagnosis, provide reassurance
❑ Explain risk of recurrence and avoidance of triggers
❑ Isometric PCM in patients with prodrome
 
Treatment
❑ Adequate hydration and salt intake
midodrine or fludrocortisone as adjunctive therapy if needed
 
Treatment (depends on the cause of the arrhythmia):
Cardiac pacing: for sinus node disease, Mobitz II AV block, BBB with positive EPS
Catheter ablation: for SVT and VT in absence of structural hearth disease
Antiarrhythmic drug therapy: for AF, failed catheter ablation
❑ Implantable cardioverter defibrillator: VT with heart disease, EPS induced VT in patients with previous MI, VT and inherited cardiomyopathy
 
 

Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]

Do's

  • Tilt testing is indicated when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.
  • Tilt testing should be considered to discriminate between reflex and OH syncope.
  • Perform tilt testing if psychiatric disease.
  • Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy.
  • If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose OH.
  • Perform CSM if patient >40 years with syncope of unknown aetiology after initial evaluation.
  • If multiple unexplained falls; perform tilt testing.
  • Consider ILR before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
  • Evaluate neurologically if syncope is due to ANF, to evaluate underlying disease.

Don'ts

  • Don't perform carotid sinus massage (CSM) in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis.
  • Don't use tilt testing for assessment of treatment.
  • Don't perform isoproterenol tilt testing in patients with ischaemic heart disease.
  • Don't use ATP test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope,.
  • Don't perform EPS if there is already indication for ICD in patients with ischemic heart with suspected arrhythmic cause.
  • Don't perform EPS in patients with normal ECK, no heart disease, and no palpitations.

References

  1. Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter |month= ignored (help)
  2. Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter |month= ignored (help)
  3. Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422‎ Check |pmid= value (help).